Holen Sie sich die Stockscreener-App
4.43
3.49%
-0.16
Handel nachbörslich:
4.43
Polypid Ltd Aktie (PYPD) Neueste Nachrichten
Research Analysts Issue Forecasts for PolyPid Q1 Earnings - Defense World
HC Wainwright Predicts PolyPid's Q1 Earnings (NASDAQ:PYPD) - MarketBeat
When Will PolyPid Ltd. (NASDAQ:PYPD) Turn A Profit? - Yahoo Finance
PolyPid Q4 Earnings Call Highlights - Defense World
PolyPid Ltd. (NASDAQ:PYPD) Q4 2025 Earnings Call Transcript - Insider Monkey
Is PolyPid Ltd. likely to announce a buybackJuly 2025 Recap & Low Risk High Win Rate Picks - mfd.ru
FY2028 Earnings Forecast for PolyPid Issued By HC Wainwright - MarketBeat
Polypid targets rolling NDA submission for D-PLEX100 by end of Q1 2026 amid advanced US partnership talks - MSN
PolyPid Earnings Call Flags Big 2026 Catalyst - TipRanks
PolyPid (PYPD) Analyst Rating Reiteration by HC Wainwright | PYP - GuruFocus
PolyPid (NASDAQ:PYPD) Earns Buy Rating from HC Wainwright - MarketBeat
PolyPid (NASDAQ:PYPD) Releases Earnings Results, Misses Expectations By $0.07 EPS - MarketBeat
Earnings call transcript: PolyPid’s Q4 2025 results miss EPS forecasts By Investing.com - Investing.com South Africa
Earnings call transcript: PolyPid’s Q4 2025 results miss EPS forecasts - Investing.com India
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results - The Manila Times
PolyPid Ltd. Advances U.S. Partnership Talks for D-PLEX₁₀₀ Following Positive FDA Feedback and Plans Rolling NDA Review - Quiver Quantitative
Preview: PolyPid's Earnings - Benzinga
Will PolyPid Ltd. stock recover after earnings2025 AllTime Highs & Capital Protection Trade Alerts - mfd.ru
Aug Closing: Is PolyPid Ltd likely to announce a buybackMarket Activity Summary & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
PolyPid (PYPD) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
PolyPid Ltd. (NASDAQ:PYPD) Sees Large Decrease in Short Interest - MarketBeat
PolyPid to Report Fourth Quarter 2025 Financial Results and Operational Highlights on February 11, 2026 - The Manila Times
PolyPid Ltd. (NASDAQ:PYPD) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Will PolyPid Gain Momentum Ahead Of Its NDA Filing? - RTTNews
Rate Hike: Will VF Corporation announce a stock splitWeekly Trade Summary & Reliable Price Action Trade Plans - baoquankhu1.vn
Aug Movers: Is AAME forming bullish engulfing patternsEarnings Trend Report & Consistent Profit Alerts - baoquankhu1.vn
Aug Movers: Will PolyPid Ltd stock recover after earnings2025 Technical Overview & Low Drawdown Momentum Ideas - baoquankhu1.vn
PolyPid calls February 2026 extraordinary meeting to approve board chair compensation - MSN
Aug Sentiment: Is PolyPid Ltd stock technically oversoldJuly 2025 Institutional & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
PYPD: D-PLEX 100's phase 3 success paves the way for FDA submission and U.S. commercialization - TradingView
Aug Catalysts: Will PolyPid Ltd stock return to pre crisis levels2025 Buyback Activity & Low Risk High Win Rate Picks - Bộ Nội Vụ
Why analysts remain bullish on PolyPid Ltd. stockQuarterly Risk Review & High Conviction Buy Zone Alerts - Улправда
Aug Big Picture: Can PolyPid Ltd. stock hit analyst price targetsJuly 2025 Earnings & Intraday High Probability Setup Alerts - Улправда
Will PolyPid Ltd. stock keep outperforming rivals2026 world cup usa national team group stage young talents high defensive line odds analysis expert opinion - ulpravda.ru
PolyPid Ltd. (NASDAQ:PYPD) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
PolyPid Ltd. (PYPD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Market Moves: Can PolyPid Ltd stock sustain free cash flow growthForecast Cut & Accurate Entry/Exit Alerts - moha.gov.vn
Contrasting PolyPid (NASDAQ:PYPD) & Crinetics Pharmaceuticals (NASDAQ:CRNX) - Defense World
PolyPid Calls February 2026 Extraordinary Meeting to Approve Board Chair Compensation - TipRanks
PolyPid files for secondary offering - MSN
PolyPid Ltd. (NASDAQ:PYPD) Short Interest Up 72.2% in December - MarketBeat
Value Recap: Will PolyPid Ltd. stock keep outperforming rivals2025 Market WrapUp & Stock Market Timing Techniques - Улправда
Will PolyPid Ltd. stock outperform international peersMarket Growth Review & Real-Time Volume Analysis Alerts - Улправда
Can PolyPid Ltd. stock sustain free cash flow growthQuarterly Growth Report & Step-by-Step Trade Execution Guides - DonanımHaber
Why PolyPid Ltd. stock attracts global investors2025 Market WrapUp & Free Expert Approved Momentum Trade Ideas - Улправда
Why PolyPid Ltd. stock could see breakout soonQuarterly Trade Review & Comprehensive Market Scan Insights - Улправда
PolyPid Appoints Brooke Story as Chairman Amid Strategic Growth - The Globe and Mail
Polypid names medtech veteran Brooke Story as board chairman - marketscreener.com
PolyPid Ltd. Appoints Brooke Story as Chairman of the Board of Directors - Quiver Quantitative
PolyPid (PYPD) appoints medtech veteran Brooke Story as board chairman - Stock Titan
PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
PolyPid price target lowered to $9 from $10 at Roth Capital - MSN
PYPD: D-PLEX100 shows strong efficacy and safety for SSI prevention, with FDA filing planned for 2026 - TradingView — Track All Markets
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):